Angeles Investments
429 Santa Monica Blvd, Suite 650, Santa Monica, CA, 90401, United States
Overview
Angeles Investments is a multi-asset investment firm that provides investment solutions to institutional and private wealth clients.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Asset Management
- Consulting
- Financial Services
Investment portfolio
- LetsGetChecked
Participated · Series C · May 2020
LetsGetChecked operates a vertically integrated, end-to-end platform that provides at-home diagnostic testing, genetic insights, virtual consultations and medication delivery. The company offers access to more than 100 laboratory panels and, following acquisitions of BioIQ, Veritas Genetics and Veritas Intercontinental, expanded services to include whole genome sequencing and pharmacogenomics. Its infrastructure includes manufacturing, logistics, state-of-the-art lab analysis, clinician support and prescription fulfillment, enabling integration with physician practices and virtual care providers via APIs. LetsGetChecked serves employers, health plans, provider groups and the public sector and has delivered more than 10 million tests and partnered with over 300 business clients across the United States, United Kingdom and EU. Founded in 2015 and co-headquartered in Dublin and New York, the company says its platform supports population-based health initiatives to address chronic conditions such as diabetes and high cholesterol. The company plans continued expansion of its 360-degree platform to scale diagnostics and virtual care access, supported by recent strategic and growth investments. LetsGetChecked provides at-home diagnostic test kits alongside telehealth and pharmacy capabilities through an end-to-end model that includes manufacturing, logistics, lab analysis, affiliated physician support, and prescription fulfillment. The company offers more than 100 validated at-home tests and has delivered over two million tests while serving more than 300 corporate customers since its 2015 founding. In the last year it says it delivered care to more than one million consumers and grew revenue by more than 1,500% year-over-year. LetsGetChecked plans to use new capital to launch "care pathways," a 360-degree remote care journey that combines telehealth, pharmacy, and diagnostics. Planned investments include expanded asynchronous chat and video telehealth, pharmacy expansion including acquiring a pharmacy in Jupiter, Florida, and continued development and rollout of new at-home tests in 2021. The company is co-headquartered in Dublin and New York and operates nationwide in the United States and in most EU countries. LetsGetChecked provides physician-approved at-home sample collection and testing with confidential results delivered online, operating a CLIA-certified high-complexity laboratory in California. Its product set includes a twin-track Coronavirus test (a rapid antibody serology result within 15 minutes followed by a PCR swab processed in its CLIA lab) and a broad catalogue of wellness, chronic condition, cancer, sexual health, fertility and pharmacogenomic tests. Users collect samples at home and return them at no additional cost via logistics partners UPS and USPS, with results available within days. The company has integrated with multiple CLIA-certified reference labs and health systems in the US and Europe and is building partnerships with insurers and employers for personalized screening and onsite employer testing. It is expanding retail distribution through 2020 and scaling supply and business operations. Following the Series C funding, LetsGetChecked intends to increase manufacturing, testing capacity and personnel to support COVID-19 testing and broader service growth across the United States and Europe. LetsGetChecked is a direct-to-consumer at-home health testing platform that enables consumers to order in-state physician-approved laboratory tests online or through retail partners. Users receive anonymized test kits shipped from the company’s ISO-accredited facility by next-day delivery, return samples for processing by CLIA-certified reference labs, and obtain results with access to in-state board-certified physicians and nurse follow-ups, including e-prescriptions at no additional cost. Its testing portfolio includes wellness, cancer screening, sexual health, fertility, genetic and pharmacogenomic tests. The platform integrates with connected health devices such as Apple Health, Fitbit and Garmin to combine lab results with wearable data for risk assessments. LetsGetChecked has integrated with large reference labs and health systems, partners with logistics providers UPS, USPS and FedEx, and is building relationships with insurers for personalized screening and home testing. The company closed a $30M Series B financing and plans to use the proceeds to scale its diagnostics consumer brand, accelerate development of its core technology platform, and expand manufacturing and logistical capabilities across North America and its served markets. LetsGetChecked is an Irish startup that offers at-home health test kits allowing customers to order, collect, and send samples for laboratory analysis across categories such as lifestyle, cancer screening, sexual health, fertility, and hormone testing. The company has built a technology and logistics platform that links customers directly to accredited laboratories, uses anonymised barcode kits, and routes results through LetsGetChecked physicians and a nursing support team who review results and call patients for positive or out-of-range findings. Users can track progress via an app dashboard and request calls from the clinical team; results are released to the dashboard after consultation when appropriate. Founded in 2014 by Peter Foley, the startup emphasizes patient-led testing and aims to mirror traditional physician-led processes while eliminating intermediaries. LetsGetChecked plans to use recent funding to scale operations, grow its full clinical support team, further invest in its technology platform and continue expanding into the U.S., where it has a New York office. Test prices vary in the U.K., ranging from £39 to £500, reflecting the company's paid consumer-facing model.
Team
Garry Duncan
Managing Director, Head of Client Development
LinkedIn